Clinical Trial: Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710274) titled 'Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)' on July 02.

Brief Summary: The primary objective of the Personalized Responses & Integrated Systems for Metabolism (PRISM-I) pilot study is to assess the feasibility of conducting a definitive randomized controlled trial evaluating precision lifestyle interventions for improving insulin resistance in adults with metabolic syndrome.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Metabolic Syndrome (MetS)

Intervention: BEHAVIORAL...